While ideally the subjects of a clinical trial should reflect the diversity of the population that’s likely to use the drug, in practice this doesn’t always happen. Trials often under-enroll women, ...
A new study led by UCLA investigators found that combining zanzalintinib, a targeted therapy drug, and atezolizumab, an ...
Authors of a recent editorial appearing in the Journal of the National Cancer Institute say opening clinical trials in follicular lymphoma (FL) to less than ideal candidates—and more like those seen ...
James is a pulmonary and critical care physician specializing in sarcoidosis. When one of my patients was first diagnosed with sarcoidosis, her specialist gave her two options: take steroids or join a ...
Introduction: The Power of PurposeWhen people think about careers in science or healthcare, their minds often jump straight ...
About RAPT Therapeutics, Inc. RAPT is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with ...
PIK3CA mutant cohort of the Phase 3 VIKTORIA-1 clinical trial is fully enrolled; Additional analysis of data from a Phase 1b clinical trial that included all patients treated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback